Actualités et événements - Smiths Medical

ICU Medical has acquired Smiths Medical

For our most recent news and events, please click here >>

To learn more about the acquisition, click here >>

Please direct all media inquiries to Tom McCall, ICU Medical, Corporate Vice President, Global Marketing at tom.mccall@icumed.com.

Affichage 1-10 de 53

Worldwide Notification Regarding the Recall of Jelco^® Hypodermic Needle-Pro^® Fixed Needle Insulin Syringe with Skewed Graduation Markings

17/06/2021, 03:28

Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels.

Plus
Introducing the Portex^® Acapella^® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System

28/04/2021, 03:38

Smiths Medical announces the launch of the acapella^® choice blue vibratory PEP therapy system. Acapella^® is designed to aid in the removal of secretions for patients who have Cystic Fibrosis, Chronic Obstructive Pulmonary Disease (COPD), asthma, lung disease with secretory problems, and patients with atelectasis.

Plus
Smiths Medical partners with Parkview Health to enhance patient and clinician safety

14/04/2021, 02:28

Parkview Health’s integration of the Smiths Medical PharmGuard® Infusion Management System enables smart pump programming and auto documentation to improve safety.

Plus
ECRI Evaluation of CADD®-Solis V4 Wireless Ambulatory Infusion System

30/03/2021, 12:20

The report highlights ECRI’s evaluation ratings, test results, and purchasing recommendations for the CADD®-Solis pump.

Plus
Launch of Portex^® EchoGlo^® Peripheral Nerve Block Portfolio

14/12/2020, 02:02

Smiths Medical, a leading medical device manufacturer, is excited to announce the launch of its EchoGlo® peripheral nerve block portfolio. This addition to the Portex® portfolio of pain management products offers customers a complete solution for regional anesthesia from pump to patient.

Plus
CADD®-Solis Wireless Communication - Cybersecurity Bulletin

20/11/2020, 07:59

Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-011 (the “Advisory”).

Plus
Worldwide Notification Regarding Potential for Inappropriate Bolus or Loading Dose Delivery in Certain Medfusion® 3500 and 4000 Infusion Pumps

19/08/2020, 08:00

Due to a software error, if a bolus or loading dose is interrupted and a specific sequence of events occurs, over- or under-delivery of a bolus or loading dose may occur.

Plus
Smiths Medical partners with U.S. government on COVID-19 vaccine efforts

15/07/2020, 10:41

The partnership with BARDA and JPEO-CBRND includes a $20 million investment for increased syringe and needle device production to support Operation Warp Speed vaccine program.

Plus
Smiths Medical Cybersecurity Bulletin

02/07/2020, 09:42

Smiths Medical is aware of, and currently monitoring, the Cybersecurity and Infrastructure Security Agency (CISA) notification concerning the Cybersecurity Vulnerability, ICSA-20-168-01

Plus
No Smiths Medical products affected by FDA and CISA "URGENT/11" vulnerabilities

16/10/2019, 09:00

The FDA and CISA announced a set of cybersecurity vulnerabilities referred to as "URGENT/11" that have the potential to introduce risks to certain medical devices or hospital networks.

Plus

Affichage 1-10 de 53

Chat Live

Contact other regions

Actualités et événements - Smiths Medical

ICU Medical has acquired Smiths Medical

Utiliser les filtres pour restreindre vos résultats.

Worldwide Notification Regarding the Recall of Jelco^® Hypodermic Needle-Pro^® Fixed Needle Insulin Syringe with Skewed Graduation Markings

Introducing the Portex^® Acapella^® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System

Smiths Medical partners with Parkview Health to enhance patient and clinician safety

ECRI Evaluation of CADD®-Solis V4 Wireless Ambulatory Infusion System

Launch of Portex^® EchoGlo^® Peripheral Nerve Block Portfolio

CADD®-Solis Wireless Communication - Cybersecurity Bulletin

Worldwide Notification Regarding Potential for Inappropriate Bolus or Loading Dose Delivery in Certain Medfusion® 3500 and 4000 Infusion Pumps

Smiths Medical partners with U.S. government on COVID-19 vaccine efforts

Smiths Medical Cybersecurity Bulletin

No Smiths Medical products affected by FDA and CISA "URGENT/11" vulnerabilities

Actualités et événements - Smiths Medical

ICU Medical has acquired Smiths Medical

Utiliser les filtres pour restreindre vos résultats.

Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe with Skewed Graduation Markings

Introducing the Portex® Acapella® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System

Smiths Medical partners with Parkview Health to enhance patient and clinician safety

ECRI Evaluation of CADD®-Solis V4 Wireless Ambulatory Infusion System

Launch of Portex® EchoGlo® Peripheral Nerve Block Portfolio

CADD®-Solis Wireless Communication - Cybersecurity Bulletin

Worldwide Notification Regarding Potential for Inappropriate Bolus or Loading Dose Delivery in Certain Medfusion® 3500 and 4000 Infusion Pumps

Smiths Medical partners with U.S. government on COVID-19 vaccine efforts

Smiths Medical Cybersecurity Bulletin

No Smiths Medical products affected by FDA and CISA "URGENT/11" vulnerabilities

Worldwide Notification Regarding the Recall of Jelco^® Hypodermic Needle-Pro^® Fixed Needle Insulin Syringe with Skewed Graduation Markings

Introducing the Portex^® Acapella^® Choice Blue Vibratory Positive Expiratory Pressure (PEP) Therapy System

Launch of Portex^® EchoGlo^® Peripheral Nerve Block Portfolio